Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Bacillus clausii and Increased Helicobacter pylori Eradication Rate

Doses used in studies

spores/day: 6 billion (median 6 billion, IQR 6 billion–6 billion) — 1 study

Time to effect

Median: 2 weeks · IQR 2 weeks–2 weeks · Range 2 weeks–2 weeks — Reported in 1 of 1 study

1 of 1 paper

Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.
- 2004-11
- RCT
- Alimentary pharmacology & therapeutics 20(10)
- - E C Nista
  - M Candelli
  - F Cremonini
  - I A Cazzato
  - M A Zocco
  - F Franceschi
  - G Cammarota
  - G Gasbarrini
  - A Gasbarrini
- PubMed: 15569121
- DOI: 10.1111/j.1365-2036.2004.02274.x
1 Insight on
- Increased Helicobacter pylori Eradication Rate
- High evidence
- Highly Cited
- Rigorous Journal
- Clinical
There were no differences in adherence to treatment and H. pylori eradication rates between groups.
Effect
Neutral
Effect size
Small
Significant
No
Dose
2 x 10^9 spores t.d.s. for 14 days